Showing 81 - 100 of 138 results
OPAL multi-purpose reactor
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Food and health
Consumers want to know that the foods they consume provide health benefits. Food materials science can monitor changes during digestion as well as assist in the development of low-fat products.
Role at ANSTO
Role at ANSTO
Role at ANSTO
The Australian Synchrotron
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
Role at ANSTO
Award recipients to present Distinguished Lectures
Award recipients Dr Richard Garrett and Dr Nigel Lengkeek with Dr Tien Pham will deliver a Distinguished Lecture on 15 November at ANSTO.
Independent Report - Safety of Building 23
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.
Role at ANSTO
Approval secured to construct new Synroc Plant
The best behind the neutron beam: Awards announced
Four annual awards in neutron scattering were announced at Australian Neutron Beam Users Group (ANBUG) and AINSE Neutron Scattering Symposium (AANSS) to individuals with strong links to ANSTO
Accelerator Systems Overview
Role at ANSTO
Delivery schedule
Latest information on the scheduled supply of our nuclear medicine production.
ANSTO's X-ray techniques support improvements in solar
Advanced X-ray techniques have revealed new structural details about the specific arrangement of atoms in conjugated polymers, an important class of materials that are used in LEDs, organic solar cells, transistors, sensors and thermoelectric power devices.
Privacy Policy
Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.
Inaugural particle therapy study tour to Japan
Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .